Showing results (1-10 of 359) with videos related to

Sort By:
Pageof 36
Cardiovascular Research|June 15, 2019
Red blood cell dysfunction: a new player in cardiovascular diseaseJohn Pernow, Ali Mahdi, Jiangning Yang, et al.
International Journal of Molecular Sciences|December 15, 2018
Altered Purinergic Receptor Sensitivity in Type 2 Diabetes-Associated Endothelial Dysfunction and Up₄A-Mediated Vascular ContractionAli Mahdi, Tong Jiao, Yahor Tratsiakovich, et al.
Frontiers in Pharmacology|August 21, 2019
The Effect of Glycemic Control on Endothelial and Cardiac Dysfunction Induced by Red Blood Cells in Type 2 DiabetesAli Mahdi, Tong Jiao, Jiangning Yang, et al.
Frontiers in Pharmacology|January 4, 2021
Erythrocytes Induce Endothelial Injury in Type 2 Diabetes Through Alteration of Vascular Purinergic SignalingAli Mahdi, Yahor Tratsiakovich, John Tengbom, et al.
Clinical Science (London, England : 1979)|July 22, 2024
Differences in endothelial function between patients with Type 1 and Type 2 diabetes: effects of red blood cells and arginaseJohn Tengbom, Eftychia Kontidou, Aida Collado, et al.
Current Opinion in Pharmacology|August 30, 2021
MicroRNA: A mediator of diet-induced cardiovascular protectionAida Collado, Hong Jin, John Pernow, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 23, 2020
Ticagrelor: a cardiometabolic drug targeting erythrocyte-mediated purinergic signaling?Bernhard Wernly, David Erlinge, John Pernow, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 16, 2023
Erythrocyte-Derived microRNAs: Emerging Players in Cardiovascular and Metabolic DiseaseEftychia Kontidou, Aida Collado, John Pernow, et al.
Pharmacology|December 20, 2021
Therapeutic Potential of Sunitinib in Ameliorating Endothelial Dysfunction in Type 2 Diabetic RatsAli Mahdi, Tong Jiao, Yahor Tratsiakovich, et al.
Pageof 36